| # | Name | Description | Category | Type | Source | Website |
|---|
| # | Opportunity | Type | Region / Country | Amount | Deadline | Source |
|---|---|---|---|---|---|---|
| 501 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of me... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advance mechanistic understanding of both biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD |
||||||
| 502 | Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of me... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). The findings are expected to advanceadavnce mechanistic understanding of both biobehavioral and neurobiologfical pathways leading to NPS. Findings may also provide insight into novel therapeutic targets that can be advanced into interventions to treat and prevent the development of NPS in AD and/or ADRD. |
||||||
| 503 | Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes e... | Grant Cash Grant | United States | Award ceiling: $200,000 | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research. |
||||||
| 504 | Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional) Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and t... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts. |
||||||
| 505 | Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) This initiative seeks to solicit applications for research projects that address the link between social disconnection including b... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide. |
||||||
| 506 | Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with compl... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular and circuit substrates of neural function. For the purposes of this NOFO, the term complex can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ, or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular and circuit mechanisms, these are neither required nor expected. Studies should not attempt to model disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components and processes. The resulting paradigms, component pathways and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic ta... |
||||||
| 507 | Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand... | Grant Cash Grant | United States | Award ceiling: $499,000 | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients' benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that employ mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research. Among many other possible endeavors, applicants in response to this FOA could propose demonstrations of how to overcome translational deficiencies of mammalian oncology models, define new uses of mammalian models or their genetics for unexplored translational challenges, advance standard practices for use of translational models, test approaches to validate and credential models, or challenge current practices for how models are used translationally |
||||||
| 508 | Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The NOFO is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this NOFO include: 1) assay development for specific biological targets and disease mechanisms relevant to the mission of participating NIH Institutes with the intent to screen for small molecule compounds that show potential as probes for use in advancing knowledge about the known targets, identifying new targets, or as pre-therapeutic leads; 2) screen implementation high throughput target-focused approaches or moderate throughput phenotypic- and fragment-based approaches to identify initial screening hits; 3) hit validation, including implementation of secondary assays that are orthogonal to the primary assay, advanced cheminformatics analysis and initial medicinal chemistry inspection to prioritize the hit set, and follow-up assays to characterize mode and mechanism of action of the validated hits; 4) hit-to-lead optimization, including SAR to optimize target engagement, selectivity and to minimize chemical liabilities, ADME, PK and PD studies, and, if appropriate, in vivo modeling to test efficacy or biological effects. |
||||||
| 509 | Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with compl... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO, the term complex can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. Studies may be either hypothesis-generating (unbiased discovery) or hypothesis-testing in design and may utilize in vivo, in situ or in vitro experimental paradigms, e.g., model organisms or human cell-based assays. While behavioral paradigms and outcome measures can be incorporated into the research design to facilitate the characterization of intracellular, transcellular, and circuit mechanisms, these are neither required nor expected. Studies should not attempt to model disorders but instead should aim to elucidate the neurobiological impact of individual or combined risk factor(s), such as the affected molecular and cellular components and their relationships within defined biological process(es). This can include the fundamental biology of these factors, components, and processes. The resulting paradigms, component pathways, and biological processes should be disseminated with sufficient detail to enrich common and/or federated data resources (e.g., those contributing to the Gene Ontology, Synaptic Gene Ontology, FAIR Data Informatics) in order to bridge the gap between disease risk factors, biological mechanism and therapeutic... |
||||||
| 510 | Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) This initiative seeks to solicit applications for research projects that address the link between social disconnection including b... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
This initiative seeks to solicit applications for research projects that address the link between social disconnection including both objective social isolation as well as perceived social isolation (otherwise known as loneliness) and suicide in late-life. Emphasis is placed on research that identifies neurobiological and environmental mechanisms associated with social isolation and loneliness that increase risk for suicidal thoughts and behavior in late-life, that uses an experimental therapeutics approach to identify targets and develop and test interventions to prevent late-life suicide, and that develops new and modifies existing service delivery models to enhance social connection in late-life to prevent suicide. |
||||||
| 511 | Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and t... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation and trajectory of the illness remain poorly understood. The purpose of this initiative is to advance translational research to better understand the emergence and trajectory of schizophrenia and related disorders in mid to late life, and to identity targets for future development of prevention and treatment efforts. |
||||||
| 512 | Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes e... | Grant Cash Grant | United States | Award ceiling: $350,000 | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research. |
||||||
| 513 | Alcohol Health Services Research (R01 Clinical Trial Optional) The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing... | Grant Cash Grant | United States | Award ceiling: $500,000 | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations. |
||||||
| 514 | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required) The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing... | Grant Cash Grant | United States | Award ceiling: $500,000 | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R01 Clinical Trial Required mechanism focusing on alcohol treatment and recovery research. This NOFO will focus broadly on topics relevant for treatment of and recovery from alcohol use disorder (AUD), including: medications development, precision medicine, behavioral therapies and mechanisms of behavioral change (MOBC), recovery, translational research, and innovative methods and technologies for AUD treatment and recovery. |
||||||
| 515 | Alcohol Health Services Research (R34 Clinical Trial Optional) The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations. |
||||||
| 516 | Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The National Institute on Alcohol Abuse and Alcoholism solicits applications for an R34 Clinical Trial Optional mechanism focusing on alcohol health services. This NOFO will broadly focus on closing the treatment gap for individuals with alcohol use disorder (AUD); within this focus, there are five major areas of emphasis: (1) increasing access to treatment for AUD, (2) making treatment for AUD more appealing, (3) examining cost structures and insurance systems, (4) conducting studies on dissemination and implementation of existing evidence-based approaches to treating AUD, and (5) reducing health disparities as a means of addressing the treatment gap in AUD for health disparity populations. |
||||||
| 517 | Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) The goal of this NOFO is to support doctoral candidates from a variety of academic disciplines for up to two years for the complet... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 7, 2026 Open | Grants.gov |
|
Source description
The goal of this NOFO is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (https://www.drugabuse.gov/funding/funding-priorities). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers. |
||||||
| 518 | IUSE/Professional Formation of Engineers: Revolutionizing Engineering Departments Revolutionizing Engineering Departments (hereinafter referred to as RED) is designed to build upon previous efforts in engineering... | Grant Cash Grant | United States | Award range: $50,000 - $2,000,000 | Open Sep 8, 2026 Open | Grants.gov |
|
Source description
Revolutionizing Engineering Departments (hereinafter referred to as RED) is designed to build upon previous efforts in engineering education research. Specifically, previous and ongoing evaluations of the NSF Engineering Education and Centers Division program and its predecessors, as well as those related programs in the Directorate for STEM Education, have shown that prior investments have significantly improved the first year of engineering students’ experiences, incorporating engineering material, active learning approaches, design instruction, and a broad introduction to professional skills and a sense of professional practice – giving students an idea of what it means to become an engineer. Similarly, the senior year has seen notable change through capstone design experiences, which ask students to synthesize the technical knowledge, skills, and abilities they have gained with professional capacities, using reflective judgment to make decisions and communicate these effectively. However, this ideal of the senior year has not yet been fully realized, because many of the competencies required in capstone design, or required of professional engineers, are only partially introduced in the first year and not carried forward with significant emphasis through the sophomore and junior years. The Directorates for Engineering (ENG) and STEM Education (EDU) are funding projects as part of the RED program, in alignment with the Improving Undergraduate STEM Education (IUSE) framework and Professional Formation of Engineers (PFE) initiative. These projects are designing revolutionar... |
||||||
| 519 | U.S. National Science Foundation Research Traineeship (NRT) Program The NSF Research Traineeship (NRT) program seeks proposals that explore ways for graduate students in research-based master’s and... | Grant Cash Grant | United States | Award range: $2,000,000 - $3,000,000 | Open Sep 8, 2026 Open | Grants.gov |
|
Source description
The NSF Research Traineeship (NRT) program seeks proposals that explore ways for graduate students in research-based master’s and doctoral degree programs to develop the skills, knowledge, and competencies needed to pursue a range of STEM careers. The program is dedicated to effective training of STEM graduate students in high priority interdisciplinary or convergent research areas, through a comprehensive traineeship model that is innovative, evidence-based, and aligned with changing workforce and research needs. Proposals are requested that address any interdisciplinary or convergent research theme of national priority, as described in section II.D below. The NRT program addresses workforce development, emphasizing broad participation, and institutional capacity building needs in graduate education. The program encourages proposals that involve strategic collaborations with the private sector, non-governmental organizations (NGOs), government agencies, national laboratories, field stations, teaching and learning centers, informal science centers, and academic partners. NRT especially welcomes proposals that reflect collaborations between NRT proposals and existing NSF Eddie Bernice Johnson Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science (INCLUDES) Initiative, Research Experiences for Undergraduates (REU), Louis Stokes Alliances for Minority Participation (LSAMP), NSF Scholarships in Science, Technology, Engineering, and Mathematics (S-STEM), and NSF STEM Ed Organizational Postdoctoral Fellowship program (ST... |
||||||
| 520 | Framework Partnership Agreements for operating grants to support non-profit organisations Expected Impact: Framework Partnership Agreements for non-profit making entities under the LIFE programme aim to strengthen the pa... | Grant Cash Grant | Europe | Not provided on the source page. Please check the official source. | Open Sep 8, 2026 Open | EU Funding & Tenders Portal |
|
Source description
Expected Impact: Framework Partnership Agreements for non-profit making entities under the LIFE programme aim to strengthen the participation of civil society in the EU policy dialogue, as well as to support implementation and enforcement of Union environmental and climate objectives, including clean energy transition, by the beneficiaries. Objective: LIFE Framework Partnership Agreements with non-profit making entities aim to strengthen the participation of civil society in the EU policy dialogue, as well as to support implementation and enforcement of Union environmental and climate objectives by the beneficiaries. The present call for proposals targets framework partnerships aimed at achieving the objectives of the Circular Economy and Quality of Life, Nature and Biodiversity, Climate Change Mitigation and Adaptation and Clean Energy Transition LIFE sub-programmes.In line with Recital... |
||||||
| 521 | A Science of Science Approach to Analyzing and Innovating the Biomedical Research Enterprise The National Science Foundation (NSF) and the National Institutes of Health (NIH) are interested in proposals that will propel our... | Grant Cash Grant | United States | Award range: $100,000 - $250,000 | Open Sep 9, 2026 Open | Grants.gov |
|
Source description
The National Science Foundation (NSF) and the National Institutes of Health (NIH) are interested in proposals that will propel our understanding of the biomedical research enterprise by drawing from the scientific expertise of the science of science policy research community. NSF promotes the progress of science by maintaining the general health of research and education across all fields of science and engineering. The Social, Behavioral and Economic Sciences (SBE) Directorate within NSF supports basic research on people and society. The SBE sciences focus on human behavior and social organizations; how social, economic, political, cultural and environmental forces affect the lives of people from birth to old age; and how people in turn shape those forces. SBE's Science of Science: Discovery, Communication and Impact Program (SoS:DCI) supports research designed to advance the scientific basis of science and innovation policy. The NIH is the U.S. federal agency charged with supporting biomedical research in the U.S.The National Institute of General Medical Sciences (NIGMS) within the NIH supports basic biomedical research that increases understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment and prevention. Both NSF and NIH believe that there are opportunities and needs for building and supporting research projects with a focus on the scientific research enterprise. The two agencies also recognize that when programmatic goals are compatible, coordinated management and funding of a research program can have a positive synerg... |
||||||
| 522 | Computer and Information Science and Engineering (CISE): Future Computing Research The NSF CISE Directorate supports research and education projects that develop new knowledge in all aspects of computing, communic... | Grant Cash Grant | United States | Award range: $600,000 - $12,000,000 | Open Sep 10, 2026 Open | Grants.gov |
|
Source description
The NSF CISE Directorate supports research and education projects that develop new knowledge in all aspects of computing, communications, and information science and engineering through the following Future Computing Research (Future CoRe) programs: Algorithmic Foundations (AF) program; Communications and Information Foundations (CIF) program; Computer Systems Research (CSR) program; Computing Education Research (CER) program; Cyber-Physical System Foundations and Connected Communities (CPS) program; Foundations of Emerging Technologies (FET) program; Human-Centered Computing (HCC) program; Information Integration and Informatics (III) program; Networking Technology and Systems (NeTS) program; Robust Intelligence (RI) program;and Software and Hardware Foundations (SHF) program; The CISE Future Computing Research program anticipates a portfolio of awards with a range of budgets and durations, including projects of smaller scope. Project durations and budgets must be commensurate with the scope of the proposed work up to the maximum limit of $1,000,000 with a duration up to 4 years. Typical projects are approximately $150,000 to $250,000 per year and are 3 to 4 years in duration. Projects are discouraged from exceeding $300,000 in any single year. Estimated program budget, number of awards, and average award size/duration are subject to the availability of funds. |
||||||
| 523 | DoW Hearing Restoration Focused Research Award Summary: The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising r... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 10, 2026 Open | Grants.gov |
|
Source description
Summary: The fiscal year 2026 (FY26) Hearing Restoration Research Program (HRRP) Focused Research Award (FRA) supports promising research that accelerates drug discovery and therapeutic development for hearing restoration after military-relevant auditory system injury. The FRA may be used to support preclinical studies and/or clinical research. Research must align with at least one of the FY26 HRRP Focus Areas. The FRA cannot be used to support clinical trials, tinnitus research or vestibular research.Distinctive Features:• The FRA offers two Funding Levels to support research at different stages and the exploration/development of ideas of different maturity levels.• Funding Level 2 includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI.• Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, and Personnel.• Programmatic review criteria include adherence to the intent of the FRA, contribution to the HRRP portfolio, relative impact, and relevance to military health. |
||||||
| 524 | DoW Vision, Mentored Clinical Research Award Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-orient... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 10, 2026 Open | Grants.gov |
|
Source description
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training. The MCRA may be used to support a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study. Research must align with at least one of the FY26 VRP Focus Areas. The MCRA may not be used to support preclinical research or clinical trials. Distinctive Features: · Key personnel must include an established clinician or Ph.D. clinical scientist, who will serve as Principal Investigator (PI) and a clinician in training (e.g., a fellow, resident, junior clinician, clinician in a Ph.D. program), who will conduct the proposed research under mentorship of the PI, with support from supporting personnel as appropriate. · The clinician in training should have sufficient time remaining in their training program to complete the research proposed under the MCRA. · Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact and Personnel. · Programmatic review criteria include adherence to the intent of the MCRA, contribution to program portfolio, relative impact and relevance to military health. · Applicants must submit documentation of Institutional Review Board (IRB)/Ethics Committee (EC) approval or exemption by January 1, 2027, in order for the MCRA application to be considered for funding. https://cd... |
||||||
| 525 | NSF Dynamic Language Infrastructure - NEH Documenting Endangered Languages This funding partnership between the National Science Foundation (NSF) and the National Endowment for the Humanities (NEH) support... | Grant Cash Grant | United States | Not provided on the source page. Please check the official source. | Open Sep 15, 2026 Open | Grants.gov |
|
Source description
This funding partnership between the National Science Foundation (NSF) and the National Endowment for the Humanities (NEH) supports projects to develop and advance knowledge concerning dynamic language infrastructure in the context of endangered human languages — languages that are both understudied and at risk of falling out of use. Made urgent by the imminent loss of roughly half of the approximately 7,000 currently used languages, this effort aims to exploit advances in human-language technology to build computational infrastructure for endangered language research. The program supports projects that contribute to data management and archiving, and to the development of the next generation of researchers. Funding can support fieldwork and other activities relevant to the digital recording, documentation and analysis, and archiving of endangered language data, including the preparation of lexicons, grammars, text samples, and databases. Funding is available in the form of one- to three-year senior research grants and conference proposals. Fellowship support is available through a separate funding opportunity administered by NEH. Note: a conference proposal should generally be submitted at least a year in advance of the scheduled date of the conference. For additional information about creating and submitting conference proposals, please refer to PAPPG Chapter II. E.9. |
||||||